USA Financial Formulas
BIIB icon

USA Financial Formulas’s Biogen BIIB Stock Holding History

USA Financial Formulas’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-3,548
Closed -$767K – 410
2026
Q2 		$767K Buy
+3,548
New +$679K 0.14% 50
2024
Q3 		– Sell
-6
Closed -$1.39K – 277
2024
Q2 		$1.39K Hold
6
– – ﹤0.01% 291
2024
Q1 		$1.29K Sell
6
-36
-86% -$8.43K ﹤0.01% 298
2023
Q4 		$10.9K Sell
42
-8,504
-100% -$2.09M ﹤0.01% 252
2023
Q3 		$2.2M Buy
8,546
+38
+0.4% +$10.2K 3.28% 5
2023
Q2 		$2.42M Sell
8,508
-3,977
-32% -$1.18M 3.72% 3
2023
Q1 		$3.47M Buy
+12,485
New +$3.45M 5.62% 1
2022
Q3 		$6K Buy
24
+19
+380% +$4.04K 0.01% 120
2022
Q2 		$1K Hold
5
– – ﹤0.01% 237
2022
Q1 		$1K Buy
+5
New +$1.09K ﹤0.01% 272
2021
Q4 		– Sell
-3,595
Closed -$1.02M – 379
2021
Q3 		$1.02M Buy
+3,595
New +$1.18M 0.91% 56
2020
Q4 		– Sell
-26
Closed -$7K – 326
2020
Q3 		$7K Sell
26
-19
-42% -$5.3K 0.01% 162
2020
Q2 		$12K Sell
45
-11,600
-100% -$3.49M 0.01% 76
2020
Q1 		$3.68M Buy
+11,645
New +$3.53M 2.35% 5
2019
Q1 		– Sell
-14,571
Closed -$5.15M – 143
2018
Q4 		$5.15M Buy
+14,571
New +$4.65M 1.28% 22
2018
Q1 		– Sell
-12,849
Closed -$4.09M – 316
2017
Q4 		$4.09M Buy
+12,849
New +$4.12M 0.97% 28

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

USA Financial Formulas's BIIB Position: Q3 2026 in Review

USA Financial Formulas sold out of Biogen (BIIB) in Q3 2026, closing a stake of 3,548 shares — an estimated $767K sold.

USA Financial Formulas first reported a position in BIIB in Q4 2017 and held it in 16 quarters. The position peaked at $5.15M in Q4 2018. 747 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • USA Financial Formulas reported no remaining Biogen position as of Q3 2026 after selling out during the quarter.
  • USA Financial Formulas sold 3,548 Biogen shares in Q3 2026, an estimated $767K.
  • USA Financial Formulas first reported a position in Biogen in Q4 2017 and held it in 16 quarters.
  • USA Financial Formulas's Biogen position peaked at $5.15M in Q4 2018.
  • 747 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on USA Financial Formulas's 13F filing for Q3 2026, filed 16 Oct 2026.